GGHYX — Invesco Health Care Fund
Data updated: 2026-06-26
GGHYX — Invesco Health Care Fund. United States Large Cap Blend / Core Health Care Equity · $1.13B AUM. Holdings, fees, performance and SEC filings.
GGHYX Fund Overview
GGHYX — Invesco Health Care Fund is a US mutual fund managed by Aim Investment Funds (invesco Investment Funds), categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Aim Investment Funds (invesco Investment Funds)
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $1.13B
- 1-year return: 4.3%
- Ticker: GGHYX
- SEC CIK: 0000826644
- SEC series ID: S000000235
- Share class ID: C000071224
GGHYX Holdings
Top 10 holdings of Invesco Health Care Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly and Co. | 9.65% |
| Johnson & Johnson | 5.85% |
| AstraZeneca PLC | 4.18% |
| Gilead Sciences, Inc. | 3.90% |
| UnitedHealth Group Inc. | 3.79% |
| argenx SE | 3.66% |
| AbbVie Inc. | 3.62% |
| McKesson Corp. | 3.43% |
| Cencora, Inc. | 3.12% |
| Invesco Private Prime Fund | 3.01% |
GGHYX Portfolio Allocation
Asset-class allocation of Invesco Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 97.0% |
| Cash & Equivalents | 7.0% |
GGHYX Performance
Total returns for GGHYX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -6.4% |
| 1 year | 4.3% |
| 3 years (annualised) | 4.6% |
| 5 years (annualised) | 2.0% |
GGHYX Risk Information
Risk metrics for GGHYX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.5%
GGHYX Costs and Fees
GGHYX costs about $82 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.82%
- Gross expense ratio: 0.82%
- Portfolio turnover: 56%
- Brokerage commissions: 4.24 bps of average net assets (SEC N-CEN)
GGHYX Cashflows
Over the 12 months to 2026-04, Invesco Health Care Fund had net outflows of $67.87M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$12.07M |
| 2026-03 | −$10.45M |
| 2026-02 | −$8.67M |
| 2026-01 | −$12.83M |
| 2025-12 | $33.90M |
| 2025-11 | −$5.05M |
GGHYX Debt Constituents
No individual debt constituents are reported in Invesco Health Care Fund's latest SEC N-PORT filing.
GGHYX Prospectus and SEC Filings
Official Invesco Health Care Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-02-27
- Prospectus (485BPOS) — filed 2025-08-28
- Prospectus (485BPOS) — filed 2025-02-28
- Portfolio holdings (N-PORT) — filed 2026-06-26
- Portfolio holdings (N-PORT) — filed 2026-04-01
- Portfolio holdings (N-PORT) — filed 2025-12-30
- Annual census (N-CEN) — filed 2026-01-14
- Annual census (N-CEN) — filed 2025-01-14
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.